Special "Tech Boom" Profile and 4 Companies That May Take Investors for a Growth Ride
January 21 2015 - 7:00AM
InvestorsHub NewsWire
New York, NY January 21th, 2015 - SmallCapIR.com initiates
coverage on Nxt-ID Inc. (NASDAQ: NXTD)
Could this be the home run of all home runs?
Now introducing the Wocket smart wallet check out the video here
http://wocketwallet.com/
Although the Wocket in our opinion is superior to any other secure
wallet on the market. Do not get hung up on this as the only
application for their proprietary technology.
My question is, could this be incorporated in to the next
generation I-phone and Android devices? If we are right this could
be a home run beyond all home runs. Not to mention the other
endless possibilities here. See website for current peripheral
applications here: http://3d-id.net/
The company’s solutions are based upon its Match-Bio™ platform, a
real-time, dynamic, multi-factor biometric authorization
technology. The Match-Bio™ platform uses physical attributes
that are unique to each user, such as their voice, fingerprints,
face, and retinas. These physical attributes are combined
with unique attributes of users’ accounts or devices to create a
security solution. The company’s Mobile-Bio™ platform
contains multiple proprietary, next generation security
technologies. The platform enables the company to produce a
range of innovative products incorporating their proprietary
methods. Each of these products can then be targeted at
different applications and market segments.
Nxt-ID, Inc. (NASDAQ: NXTD) is an early stage technology company
focused on providing biometric products, solutions, and services
for applications that have a need for biometric secure access
control. The company was founded in 2011 and is headquartered
in Shelton Connecticut. The company introduced its first commercial
product at the 2015 Consumer Electronics Show in Las Vegas, where
it was named as one of “11 Hot Products at CES” by Wired.com.
Full Profile Here:
could-we-be-sitting-on-the-next-smart-phone-tech?
CapRock Research has also initiated coverage with an overweight/buy
recommendation and $4.80 Near Term Price Target. CapRock Research
full report:
NXTD-Analyst-Report
Other stocks on watch this week
Dragon Polymers, Inc. (OTCBB: DRAG) is recycler of industrial
polymers through landfill remediation. As a result of this the
company is focusing its efforts in the reclamation of polymers,
specifically Polyethylene Terephthalate, ASR, Nylon 6 and Nylon6/6,
Polypropylene and Polyester.
Though no announcement has been made, investors speculate that a
merger with a private enterprise is about to happen.
Find out what DRAG does and read the details about a potential
merger here, in this report: http://bit.ly/-DRAG-AnalstReport
Electronic Cigarettes International Group, Ltd. (OTCQB: ECIG)
manufactures, markets, and distributes many of the world’s leading
e-cigarette and vaping brands. They have a full range of products,
from disposable and rechargeable “cig-a-like” analogs, to advanced
vaping products, and specialty items.
The company has announced a shareholder meeting in February 2015 to
consider a reverse stock split. Read about it, and get the details
in this report: http://bit.ly/-ECIG-AnalystReport
Minerco Resources, Inc. (OTCBB: MINE) is the parent company of
Level 5 Beverage Company, Inc., a specialty beverage company which
develops, produces, markets and distributes a diversified portfolio
of forward-thinking, good-for-you consumer brands. The Level 5
brand umbrella includes: VitaminFIZZ(R), Vitamin Creamer(R), Coffee
Boost(TM), The Herbal Collection(TM) and LEVEL 5(R).
The company has a new advertising campaign for its VitaminFIZZ
product. You can find details of the ad campaign at the following
link: http://bit.ly/-MINE--AnalystReport
Cellceautix Corp. (OTCBB: CTIX) is an early stage developmental
biopharmaceutical company...with six pharmaceutical compound
candidates that are designed for treatment of diseases which may be
either existing or diseases identified in the future. The Company
spends most of its efforts and resources on its anti-cancer
compound, Kevetrin, for the treatment of head and neck cancers.
If you are curious about the CTIX products and their development
stages, read the report you will find here: http://bit.ly/--CTIX--AnalystReport
About Small Cap IR
We make the connection between sophisticated investors and high
quality small cap companies. An issuer of reports written by
chartered financial analysts (CFA’s) who provide a straightforward
assessment of the profiled company and have pledged to remain free
of influence when writing research reports. They include stocks
traded in the NYSE, NASDAQ, and OTCBB exchanges.
For more information and services provided beyond this release
please use contact information provided below.
Forward-Looking Disclaimer
This report may contain certain forward-looking statements and
information, as defined within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934, and is subject to the Safe Harbor created by those
sections. This material contains statements about expected future
events and/or financial results that are forward-looking in nature
and subject to risks and uncertainties. Such forward- looking
statements by definition involve risks, uncertainties and other
factors, which may cause the actual results, performance or
achievements of mentioned company to be materially different from
the statements made herein.
Compliance Procedure
Content is researched, written and reviewed on a best-effort basis
by a 3rd party research analyst. However, we are only human and are
prone to make mistakes. If you notice any errors or omissions,
please notify us below. We do not engage in high frequency
trading.
A full disclaimer can be found by viewing the analyst report.
If you wish to have a company covered in more detail by our team,
or wish to learn more about our services, please contact us at
editor@smallcapir.com. For any urgent concerns or inquiries please
contact us at editor@smallcapir.com.
Source: Small Cap IR
Contact: editor@smallcapir.com
Innovation Pharmaceuticals (CE) (USOTC:IPIX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Innovation Pharmaceuticals (CE) (USOTC:IPIX)
Historical Stock Chart
From Sep 2023 to Sep 2024